Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice.

about

Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice.

Item

http://www.wikidata.org/entity/Q53837345

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice.

@en

Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice.

@nl

type

Item

label

Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice.

@en

Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice.

@nl

prefLabel

Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice.

@en

Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice.

@nl

P1476

Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice.

@en

P2093

Aaron Kirchhoff

http://www.w3.org/2001/XMLSchema#string

Angel Gandarilla

http://www.w3.org/2001/XMLSchema#string

John A Moss

http://www.w3.org/2001/XMLSchema#string

Marc M Baum

http://www.w3.org/2001/XMLSchema#string

Philippe A Gallay

http://www.w3.org/2001/XMLSchema#string

Richard B Pyles

http://www.w3.org/2001/XMLSchema#string

Udayan Chatterji

http://www.w3.org/2001/XMLSchema#string

P2860

Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

How do viral and host factors modulate the sexual transmission of HIV? Can transmission be blocked?

A virocidal amphipathic -helical peptide that inhibits hepatitis C virus infection in vitro

Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virus

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection

Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice

P304

1-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1874357901812010001

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29541273

http://www.w3.org/2001/XMLSchema#string

P932

5842390

http://www.w3.org/2001/XMLSchema#string